Sentence: Bevacizumab in combination with interferon alfa is now approved for treatment-naïve advanced renal cell carcinoma ( RCC ) in both the US and Europe .
Drug combination annotation:
[{'class': 'POS', 'spans': ['Bevacizumab', 'interferon alfa'], 'is_context_needed': False}]